Angiostatic properties of sulindac and celecoxib in the experimentally induced inflammatory colorectal cancer. [electronic resource]
Producer: 20131209Description: 205-27 p. digitalISSN:- 1559-0283
- 1,2-Dimethylhydrazine -- toxicity
- Animals
- Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Celecoxib
- Colorectal Neoplasms -- chemically induced
- Cyclooxygenase 2 -- genetics
- Dinoprostone -- metabolism
- Interferon-gamma -- genetics
- Interleukin-1beta -- genetics
- Interleukin-2 -- genetics
- Male
- Matrix Metalloproteinase 2 -- genetics
- Matrix Metalloproteinase 9 -- genetics
- NF-kappa B -- genetics
- Nitric Oxide Synthase Type II -- genetics
- Pyrazoles -- therapeutic use
- RNA, Messenger -- metabolism
- Rats
- Rats, Sprague-Dawley
- STAT3 Transcription Factor -- genetics
- Sulfonamides -- therapeutic use
- Sulindac -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.